Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397222
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-29
Brief Title:
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Organization:
Second Affiliated Hospital of Guangzhou Medical University
Organization Data
Organization:
Second Affiliated Hospital of Guangzhou Medical University
Class:
OTHER
Study ID:
MIIR-16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None